Đặc điểm lâm sàng của sự dung nạp miễn dịch sau ghép gan nhi khoa
Tóm tắt
Từ khóa
#dung nạp miễn dịch #ghép gan nhi khoa #thuốc ức chế miễn dịch #bệnh lý mật #chức năng ganTài liệu tham khảo
Liu XQ, Hu ZQ, Pei YF, et al. Clinical operational tolerance in liver transplantation: state-of-the-art perspective and future prospects. Hepatobiliary Pancreat Dis Int. 2013;12(1):12–33.
Calne R, Watson CJ. Some observations on prope tolerance. Curr Opin Organ Transplant. 2011;16(4):353–8.
Ronca V, Wootton G, Milani C, et al. The immunological basis of liver allograft rejection. Front Immunol. 2020;11:2155.
Du X, Chang S, Guo W, et al. Progress in liver transplant tolerance and tolerance-inducing cellular therapies. Front Immunol. 2020;11:1326.
Lau AH, Vitalone MJ, Haas K, et al. Mass cytometry reveals a distinct immunoprofile of operational tolerance in pediatric liver transplantation. Pediatr Transplant. 2016;20(8):1072–80.
Koshiba T, Li Y, Takemura M, et al. Clinical, immunological, and pathological aspects of operational tolerance after pediatric living-donor liver transplantation. Transpl Immunol. 2007;17(2):94–7.
Feng S, Demetris AJ, Spain KM, et al. Five-year histological and serological follow-up of operationally tolerant pediatric liver transplant recipients enrolled in WISP-R. Hepatology. 2017;65(2):647–60.
Lee JH, Lee SK, Lee HJ, et al. Withdrawal of immunosuppression in pediatric liver transplant recipients in Korea. Yonsei Med J. 2009;50(6):784–8.
Kim MH, Akbari O, Genyk Y, et al. Immunologic benefit of maternal donors in pediatric living donor liver transplantation. Pediatr Transplant. 2019;23(7):e13560.
Feng S, Bucuvalas J. Tolerance after liver transplantation: where are we? Liver Transpl. 2017;23(12):1601–14.
Tanimine N, Ohira M, Tahara H, et al. Strategies for deliberate induction of immune tolerance in liver transplantation: from preclinical models to clinical application. Front Immunol. 2020;11:1615.
Jiang Y, Que W, Zhu P, et al. The role of diverse liver cells in liver transplantation tolerance. Front Immunol. 2020;11:1203.
Przybyszewski EM, Verna EC, Lobritto SJ, et al. Durable clinical and immunologic advantage of living donor liver transplantation in children. Transplantation. 2018;102(6):953–60.
Todo S, Yamashita K, Goto R, et al. A pilot study of operational tolerance with a regulatory T-cell-based cell therapy in living donor liver transplantation. Hepatology. 2016;64(2):632–43.
Banff Working Group on Liver Allograft Pathology. Importance of liver biopsy findings in immunosuppression management: biopsy monitoring and working criteria for patients with operational tolerance. Liver Transpl. 2012;18(10):1154–70.
Takatsuki M, Uemoto S, Inomata Y, et al. Weaning of immunosuppression in living donor liver transplant recipients. Transplantation. 2001;72(3):449–54.
Feng S, Bucuvalas JC, Mazariegos GV, et al. Efficacy and safety of immunosuppression withdrawal in pediatric liver transplant recipients: moving toward personalized management. Hepatology. 2021;73(5):1985–2004.